Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:30:36 EDT Sun 28 Apr 2024
Enter Symbol
or Name
USA
CA



News for C:TLT from 2023-04-27 to 2024-04-26 - 38 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2024-04-24 20:09C:TLTTheralase Technologies Inc0.165Private PlacementTheralase 4,167,778-share private placement
2024-04-24 11:17C:TLTTheralase Technologies Inc0.165News ReleaseTheralase closes $750,200 private placement
2024-04-05 09:45C:TLTTheralase Technologies Inc0.18News ReleaseTheralase receives Canadian patent for cancer vaccine
2024-03-27 11:29C:TLTTheralase Technologies Inc0.18News ReleaseTheralase Technologies loses $4.57-million in 2023
2024-03-27 07:12C:TLTTheralase Technologies Inc0.18SEDAR MD & ASEDAR MD & A
2024-03-27 07:11C:TLTTheralase Technologies Inc0.18SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-03-26 11:05C:TLTTheralase Technologies Inc0.18News ReleaseTheralase to hold advisory meetings April 12, May 4
2024-02-13 20:47C:TLTTheralase Technologies Inc0.19Private PlacementTheralase 6,666,670-share private placement
2024-02-08 11:17C:TLTTheralase Technologies Inc0.20News ReleaseTheralase hires Jewett as consultant
2024-02-05 16:53C:TLTTheralase Technologies Inc0.165News ReleaseTheralase closes $1.2-million private placement
2024-01-15 10:51C:TLTTheralase Technologies Inc0.185News ReleaseTheralase talks phase II bladder cancer study
2023-12-05 19:40C:TLTTheralase Technologies Inc0.18Private PlacementTheralase 5,318,183-share private placement
2023-11-29 19:36C:TLTTheralase Technologies Inc0.185SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-29 19:32C:TLTTheralase Technologies Inc0.185SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-29 18:56C:TLTTheralase Technologies Inc0.185News ReleaseTheralase loses $3.57-million in nine months
2023-11-29 16:49C:TLTTheralase Technologies Inc0.185News ReleaseTheralase closes $1.17-million private placement
2023-11-17 16:38C:TLTTheralase Technologies Inc0.185News ReleaseTheralase arranges $1.5-million private placement
2023-10-23 18:26C:TLTTheralase Technologies Inc0.26News ReleaseTheralase arranges minimum $3.5-million offering
2023-10-23 10:30C:TLTTheralase Technologies Inc0.26News ReleaseTheralase receives Health Cda OK for study amendment
2023-10-16 10:17C:TLTTheralase Technologies Inc0.265News ReleaseTheralase releases initial bladder cancer study results
2023-10-05 11:21C:TLTTheralase Technologies Inc0.23News ReleaseTheralase files U.S. enhanced immunotherapy patent
2023-09-29 09:27C:TLTTheralase Technologies Inc0.23News ReleaseTheralase demonstrates 8-year shelf life for Ruvidar
2023-09-27 10:20C:TLTTheralase Technologies Inc0.215News ReleaseTheralase completes non-GLP toxicology analysis for GBM
2023-09-21 16:39C:TLTTheralase Technologies Inc0.23News ReleaseTheralase grants options to acquire 360,000 shares
2023-09-20 17:44C:TLTTheralase Technologies Inc0.23SEDAR Annual Information FormSEDAR Annual Information Form
2023-09-14 19:04C:TLTTheralase Technologies Inc0.245Private PlacementTheralase 1.84-million-share private placement
2023-09-07 16:42C:TLTTheralase Technologies Inc0.235News ReleaseTheralase closes $460,000 private placement
2023-08-29 16:56C:TLTTheralase Technologies Inc0.265News ReleaseTheralase loses $2.56-million over six months
2023-08-29 10:10C:TLTTheralase Technologies Inc0.265SEDAR Interim MD & ASEDAR Interim MD & A
2023-08-29 09:58C:TLTTheralase Technologies Inc0.265SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-07-05 19:00C:TLTTheralase Technologies Inc0.25Private PlacementTheralase 4.8-million-share private placement
2023-06-30 16:46C:TLTTheralase Technologies Inc0.27News ReleaseTheralase closes $1.2-million private placement
2023-06-06 13:13C:TLTTheralase Technologies IncNews ReleaseTheralase appoints Lbiati as director
2023-05-30 21:02C:TLTTheralase Technologies Inc0.255SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-05-30 21:02C:TLTTheralase Technologies Inc0.255SEDAR MD & ASEDAR MD & A
2023-05-30 19:45C:TLTTheralase Technologies Inc0.255News ReleaseTheralase loses $1.4-million in Q1 2023
2023-05-24 19:22C:TLTTheralase Technologies Inc0.24News ReleaseTheralase reappoints DuMoulin-White as president, CEO
2023-05-10 10:41C:TLTTheralase Technologies Inc0.24News ReleaseTheralase reclassifies patients in bladder cancer study